Picture of Optomed Oyj logo

OPTOMED — Optomed Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Optomed Reports Q4 EBITDA Loss At EUR 1.3 Million

Feb 10 (Reuters) - Optomed Oyj OPTOMED.HE:

Q4 REVENUE EUR 4.812 MILLION

Q4 EBITDA MARGIN -27.7%

Q4 EBITDA EUR -1.333 MILLION

Q4 NET INCOME EUR -1.885 MILLION

EXPECTS ITS FULL YEAR 2026 REVENUE TO GROW COMPARED TO 2025

STRATEGIC DIRECTION REMAINS UNCHANGED

EXPECT CONTINUED UNCERTAINTY AND REDUCED PREDICTABILITY IN U.S. MARKET ENVIRONMENT IN 2026

WILL CONTINUE TO FOCUS ON EXPANDING AI-ENABLED SCREENING SOLUTIONS

Source text: ID:nWkr4lKhcb

Further company coverage: OPTOMED.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Optomed Oyj

See all news